TGFB1 and neoplasm: We observed that TGFB1 was co-expressed with proteins involved in angiogenesis and tumor immune escape in ccRCC (Fig. 6l), indicating that the alternative angiogenesis driven by TGFB1 resulted in Sunitinib resistance.